Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm.

@article{Guillaume2018UsefulnessAS,
  title={Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm.},
  author={Marie-Paule Guillaume and H{\'e}lo{\"i}se Reumaux and François Dubos},
  journal={Cardiology in the young},
  year={2018},
  volume={28 5},
  pages={739-742}
}
Kawasaki disease is an acute self-limited vasculitis of unknown aetiology. The prognosis depends mainly on coronary damage. There is no consensus regarding optimal adjunctive therapeutics for refractory forms to treatment by intravenous immunoglobulins and corticosteroids. We report the case of an 18-month-old infant with refractory Kawasaki disease… CONTINUE READING